Karen Finerman has been president of Metropolitan Capital Advisors Inc. since 1992 when she co-founded the firm. Prior to June 1992, she was the lead research analyst for the Risk Arbitrage department at Donaldson, Lufkin & Jenrette Securities Corporation.
She received a B.S. in economics from the University of Pennsylvania's Wharton School in 1987, with a concentration in finance.
Finerman is on the board of the Michael J. Fox Foundation for Parkinson's Research and is also a trustee of the Montefiore Medical Center in the Bronx, N.Y., where she serves on their investment committee.
Follow Karen Finerman on Twitter @karenfinerman.
There's a slow and steady path toward S&P 3,000, Morgan Stanley's Adam Parker says.
Ahead of speculation about Apple's event, investors are focused on long-term value that the tech company will generate.
Tesla Motors has a "staggering" ability to ramp up production, said Stifel Nicolaus auto analyst James Albertine.